News | May 29, 2024
IGC Pharma announces patient enrollment at Neurostudies in Phase 2 trial investigating IGC-AD1
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
The product is used to treat amyotrophic lateral sclerosis
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
Subscribe To Our Newsletter & Stay Updated
